CoChat

High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population

Open access
Wagner, Dimitrios L., Amini, Leila, Wendering, Desiree J., Burkhardt, Lisa-Marie, Akyüz, Levent, Reinke, Petra, Volk, Hans-Dieter, Schmueck-Henneresse, Michael · 2019 · Nature Medicine

Published version of a preprint

The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

The discovery of the highly efficient site-specific nuclease system CRISPR-Cas9 from Streptococcus pyogenes has galvanized the field of gene therapy 1,2. The immunogenicity of Cas9 nuclease has been demonstrated in mice 3,4. Preexisting immunity against therapeutic gene vectors or their cargo can decrease the efficacy of a potentially curative treatment and may pose significant safety issues 3-6. S. pyogenes is a common cause for infectious diseases in humans, but it remains unclear whether it induces a T cell memory against the Cas9 nuclease 7,8. Here, we show the presence of a preexisting ubiquitous effector T cell response directed toward the most widely used Cas9 homolog from S. pyogenes (SpCas9) within healthy humans. We characterize SpCas9-reactive T cells within the CD4/CD8 compartments for multi-effector potency, cytotoxicity, and lineage determination. In-depth analysis of SpCas9-reactive T cells reveals a high frequency of SpCas9-reactive regulatory T cells that can mitigate SpCas9-reactive effector T cell proliferation and function in vitro. Our results shed light on T cell-mediated immunity toward CRISPR-associated nucleases and offer a possible solution to overcome the problem of preexisting immunity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-018-0204-6

Cites

53 of 54 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

4 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 407

Metadata

Authors
Wagner, D. L., Amini, L., Wendering, D. J., Burkhardt, L.-M., Akyüz, L., Reinke, P., Volk, H.-D., & Schmueck-Henneresse, M.
Affiliations
  • Berlin-Brandenburger Centrum für Regenerative Therapien (DE)
  • Charité – Universitätsmedizin Berlin (DE)
Venue
Nature Medicine
Published
2018-10-29
Volume
25
Issue
2
Pages
242-248
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W2897403793
Cited by
399
References
52
Citations by year
2026: 31 · 2025: 43 · 2024: 37 · 2023: 49 · 2022: 52 · 2021: 69 · 2020: 62 · 2019: 51 · 2018: 4
FWCI
16.63
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Medicine (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed (publishedVersion)
Funders
  • Deutsche Forschungsgemeinschaft (SFB/TR 36, Project A3, DFG-SFB-TR36-project A3)
  • Bundesministerium für Bildung und Forschung
  • Berlin-Brandenburger Centrum für Regenerative Therapien
  • Berlin Institute of Health
  • Einstein Centrum für Regenerartive Therapien, Charité-Universitätsmedizin Berlin
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Oncology › CAR-T cell therapy research
Keywords
Streptococcus pyogenes, SpCas9, CRISPR/Cas9, pre-existing immunity, T cell response, regulatory T cells, effector T cells, gene therapy safety, immunogenicity, CD4+ T cells, CD8+ T cells, T cell cytotoxicity
MeSH terms
CRISPR-Associated Protein 9, Adolescent, Adult, Female, Humans, Interferon-gamma, Male, Middle Aged, Streptococcus pyogenes, T-Lymphocytes, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. https://app.cochat.ai/papers/10.1038/s41591-018-0204-6
The paper
Wagner, D. L., Amini, L., Wendering, D. J., Burkhardt, L.-M., Akyüz, L., Reinke, P., Volk, H.-D., & Schmueck-Henneresse, M. (2019). High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nature Medicine. https://doi.org/10.1038/s41591-018-0204-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.